NCT00599170View on ClinicalTrials.gov

Rituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 10, 2008

Primary Completion Date

January 10, 2020

Study Completion Date

January 10, 2021

Conditions
Diffuse, Large B-Cell, Lymphoma
Interventions
DRUG

Rituximab

375 mg/m2 IV

Trial Locations (1)

90089

USC Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT00599170 - Rituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma | Biotech Hunter | Biotech Hunter